H. C. Falkson
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
Papers in
- Oncology 19
- Cancer Treatment and Pharmacology 12
- Colorectal Cancer Treatments and Studies 3
- Cancer Risks and Factors 2
-
- Breast Cancer Treatment Studies 8
- Co-authors
- Geoffrey FalksonCarla I. FalksonD. C. TormeyR GrayD C TormeyJohann RaatsAvital CnaanLouise Ryan
- Journals
- Journal of Clinical Oncology (5 papers)Cancer (4 papers)Annals of Oncology (3 papers)Cancer Treatment Reviews (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- South AfricaUnited StatesUnited Kingdom
In The Last Decade
H. C. Falkson
31 papers receiving 944 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 349
- Oncology 608
- Hepatology 85
- Genetics 256
- Pathology and Forensic Medicine 138
Countries citing papers authored by H. C. Falkson
This map shows the geographic impact of H. C. Falkson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. C. Falkson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. C. Falkson more than expected).
Fields of papers citing papers by H. C. Falkson
This network shows the impact of papers produced by H. C. Falkson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. C. Falkson. The network helps show where H. C. Falkson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H. C. Falkson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 53 | |
| 2 | 1996 | 138 | |
| 3 | 1993 | 1 | |
| 4 | 1993 | 2 | |
| 5 | 1992 | 58 | |
| 6 | 1992 | 2 | |
| 7 | 1991 | 2 | |
| 8 | 1991 | 131 | |
| 9 | 1990 | 8 | |
| 10 | 1990 | 60 | |
| 11 | 1989 | 16 | |
| 12 | 1988 | 24 | |
| 13 | Prognostic factors for survival in hepatocellular carcinoma. | 1988 | 84 |
| 14 | 1982 | 13 | |
| 15 | 1980 | 45 | |
| 16 | 1979 | 25 | |
| 17 | 1978 | 26 | |
| 18 | 1975 | 79 | |
| 19 | RADIOSENSITIZATION BY PROCARBAZINE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA. | 1970 | 5 |
| 20 | 1965 | 2 |
About H. C. Falkson
H. C. Falkson is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Genetics and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), Estrogen and related hormone effects (8 papers), Breast Cancer Treatment Studies (8 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer Risks and Factors (2 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Cancer Research (349 citations), Oncology (608 citations), Hepatology (85 citations), Genetics (256 citations) and Pathology and Forensic Medicine (138 citations). H. C. Falkson has collaborated with scholars based in South Africa, United States and United Kingdom. Frequent co-authors include Geoffrey Falkson, Carla I. Falkson, D. C. Tormey, R Gray, D C Tormey, Johann Raats, Avital Cnaan, Louise Ryan, Allan J. Schutt and T. E. Davis. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Oncology, Cancer Treatment Reviews and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.